Success Metrics

Active Trials

4(100%)

Phase Distribution

Ph phase_1

25%

Ph phase_2

25%

Ph not_applicable

25%

Ph phase_4

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

Phase 2Efficacy & side effects

1(25.0%)

Phase 4Post-market surveillance

1(25.0%)

N/ANon-phased studies

1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Detailed Status

Recruiting3

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 4

Trials by Phase

Phase 11 (25.0%)

Phase 21 (25.0%)

Phase 41 (25.0%)

N/A1 (25.0%)

Trials by Status

recruiting375%

active_not_recruiting125%

Recent Activity

4 active trials

Showing 4 of 4

active_not_recruitingphase_4

RELIEF-PD: Crisugabalin for Nociplastic Pain in Parkinson's Disease

NCT07483398

recruitingphase_1

Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety

NCT07453862

recruitingnot_applicable

The Efficacy and Safety of Pregabalin and Crisugabalin in Patients With Fibromyalgia

NCT07196657

recruitingphase_2

Crisugabalin for Radiotherapy-Related Neuropathic Pain

NCT06766916

Clinical Trials (4)

Showing 4 of 4 trials

NCT07483398Phase 4

RELIEF-PD: Crisugabalin for Nociplastic Pain in Parkinson's Disease

Active Not Recruiting

NCT07453862Phase 1

Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety

Recruiting

NCT07196657Not Applicable

The Efficacy and Safety of Pregabalin and Crisugabalin in Patients With Fibromyalgia

Recruiting

NCT06766916Phase 2

Crisugabalin for Radiotherapy-Related Neuropathic Pain

Recruiting

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4